Drawing for ROMBALA

USPTO serial 97794181

ROMBALA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
BRENNER, BRANDI M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ROMBALA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janina Gorbach

Janina Gorbach Pfizer Inc.66 Hudson Boulevard EastNew York, NY 10001-2192United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human useABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2025MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Sep 9, 2025ABN5ABANDONMENT - AFTER PUBLICATION
Sep 8, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED
Jul 1, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2025EX3GSOU EXTENSION 3 GRANTED
Jun 30, 2025EXT3SOU EXTENSION 3 FILED
Jun 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2024EX2GSOU EXTENSION 2 GRANTED
Dec 19, 2024EXT2SOU EXTENSION 2 FILED
Dec 19, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2024EX1GSOU EXTENSION 1 GRANTED
Jun 28, 2024EXT1SOU EXTENSION 1 FILED
Jun 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 20, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 26, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 6, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2023DOCKASSIGNED TO EXAMINER
Mar 27, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 4, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 17, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance